About US
Contact us
-
GlaxoSmithKline settles US drug dispute for $3bnGlaxoSmithKline has agreed to settle disputes with the US Government over the way it marketed and developed its drugs for $3bn. The final settlement, which is expected to address civil and criminal l2011/11/4
-
Sanofi to top sales league, ousting PfizerSanofi is set to knock Pfizer off the top of the pharmaceutical sales table next year, according to EvaluatePharma sales forecasts. Aided by acquisitions including US biotechnology company Genzyme,2011/11/3
-
Pfizer acquires IcagenPfizer, through its wholly owned subsidiary Eclipse Acquisition, has completed the acquisition of biopharmaceutical company Icagen. As per the agreement, each issued and outstanding share of Icagen c2011/11/3
-
SFDA Commissioner Shao Mingli meets Director of Health of Hong Kong SAR GovernmentOn the afternoon of October 31, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA) met with the visiting Dr. P.Y. LAM, Director of Health of the Government of the Hong Ko2011/11/3
-
Biotie and Merck turn their backs on NewronFinland's Biotie Therapies has pulled out of its planned merger with Newron Pharmaceuticals following a decision by Merck to return the full global rights to investigational Parkinson's disease drug s2011/11/2
-
Obama orders FDA to tackle drug shortageUS President Barack Obama has ordered the Food and Drug Administration (FDA) to remedy the problem of drug shortages in the country. Over the past year, the majority of hospitals in the US have been2011/11/2
-
Merck net income rise on key drug performanceMerck & Cohas reported a surge in third quarter net income, based on strong sales of key drugs, including Januvia, Janumet and Gardasil. Diabetes medications Januvia and Janumet reported sales in2011/11/2
-
Bristol-Myers Squibb reports strong revenue riseBristol-Myers Squibb (BMS) has reported strong third quarter results, announcing an 11% increase in revenue to $5.35bn attributed to the company's blood thinning drug Plavix. Plavix turnover rose 8%2011/11/2
-
SFDA Commissioner Shao Mingli meets Director General of the Center for Genetic Engineering and Biotechnology of CubaOn October 28, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA), met with the visiting delegation led by the Director General of the Center for Genetic Engineering2011/11/1
-
SFDA issues the Third Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 2011SFDA issues the Third Summary of Announcements of Illegal Drug, Medical Device, and Health Food Advertisements in 20112011/11/1